+86.9%
DOCN vs MRNA
+50.7%
+36.2%
-84.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -3.9% | +4.6% | +1.1% |
| 7D | -0.1% | -17.6% | +17.5% | +1.9% |
| 30D | -19.5% | -5.1% | -14.4% | -19.2% |
| 3M | -41.3% | +220.8% | -262.1% | -53.3% |
| 6M | -48.7% | +321.7% | -370.4% | -63.0% |
| YTD | +65.1% | +601.3% | -536.2% | -0.9% |
| 1Y | +78.3% | +735.2% | -656.9% | +0.9% |
| 3Y | +174.9% | +170.5% | +4.3% | +95.6% |
| 5Y | -38.4% | -14.6% | -23.8% | -44.1% |
| All | +86.9% | +50.7% | +36.2% | +29.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling